|
|
Volumn 275, Issue 4, 1996, Pages 273-
|
|
First protease inhibitor approved for treatment of HIV
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
SAQUINAVIR;
ZALCITABINE;
ZIDOVUDINE;
ISOQUINOLINE DERIVATIVE;
NEW DRUG;
PROTEINASE INHIBITOR;
QUINOLINE DERIVATIVE;
CARMUSTINE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INFORMATION;
DRUG LABELING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
NOTE;
PRIORITY JOURNAL;
MEDICAL LITERATURE;
POLICY;
PUBLICATION;
ARTICLE;
DRUG APPROVAL;
GLIOMA;
INFORMATION SERVICE;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
PUBLISHING;
STANDARD;
UNITED STATES;
DRUG SCREENING;
CANCER CHEMOTHERAPY;
LYMPHOCYTE ACTIVATION;
CARCINOMA, RENAL CELL;
DRUG APPROVAL;
DRUGS, INVESTIGATIONAL;
GLIOMA;
HIV PROTEASE INHIBITORS;
HUMANS;
INFORMATION SERVICES;
ISOQUINOLINES;
KIDNEY NEOPLASMS;
PUBLISHING;
QUINOLINES;
SAQUINAVIR;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 13344261975
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.275.4.273 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
